robecosamen
COVID 19—a necessary catalyst for accelerating innovative change

COVID 19—a necessary catalyst for accelerating innovative change

11-06-2020 | Article
In times of stability and steady equilibriums, innovative change is incremental. However, sudden shocks can accelerate change. The coronavirus pandemic is a shock that will ignite new ideas and innovation as well as reduce barriers to adoption by slow-moving industries accustomed to steady-state, business-as-usual scenarios.
  • Pieter Busscher
    Pieter
    Busscher
    Senior Portfolio Manager - RobecoSAM Smart Materials Strategy

Speed read

  • COVID-19 pandemic has taken companies beyond business-as-usual scenarios 
  • Continued uncertainties and new realities are driving technological innovation and adoption across industrial sectors
  • Unprecedented times will create unprecendented opportunities for companies within the Smart Materials Strategy

Though COVID-19 has straight-jacketed many industries in the short-term, over the long-term, the pain and strain caused by supply chain disruptions and mandatory lockdowns will drive renewed interest and investments in innovative technologies that prosper society.

“Necessity is the mother of all invention.“

If invention requires necessity, then accelerated innovation requires disruption.

The devastating disruption of COVID-19 provides the necessity that will catalyze industries to re-assess, re-focus, and re-double efforts to mitigate and manage risks within operations and supply chains. 

Though the coronavirus pandemic temporarily halted business operations and GDP growth, it has not and cannot halt the need for technological advances that produce better outputs with fewer inputs. 

Investing in disruptive products and processes that optimize materials, resources, and factors of production forms the core of the Smart Materials investment strategy. 

Logo

Disclaimer RobecoSAM

The information contained on these pages is solely intended for Qualified Investors in accordance with the Swiss Collective Investment Schemes Act of 23 June 2006 (“CISA”) domiciled in Switzerland, Professional Clients in accordance with Annex II of the Markets in Financial Instruments Directive II (“MiFID II”) domiciled in Liechtenstein, Austria, Germany, Sweden, UK, France, Netherlands or Italy holding a distributor license or herewith requesting respective information on products and services in their capacity as Professional Clients.
Some funds about which information is shown on these pages fall outside the scope of the Swiss Collective Investment Schemes Act of 26 June 2006 (“CISA”) and therefore do not (need to) have a license from or registration with the Swiss Financial Market Supervisory Authority (FINMA). Some funds about which information is shown on this website may not be available in your domicile country.
To view the Robeco/RobecoSAM products that are registered/available in your country, please go to the respective Fund Selector and select your country of domicile. Neither information nor any opinion expressed on this website constitutes a solicitation, an offer or a recommendation to buy, sell or dispose of any investment, to engage in any other transaction or to provide any investment advice or service. An investment in a Robeco or RobecoSAM product should only be made after reading the related legal documents such as management regulations, prospectuses, annual and semi-annual reports, which can all be obtained free of charge at the Robeco offices in each country where Robeco has a presence.

By clicking “I agree” you confirm that you/the company you represent falls under one of the above-mentioned categories of addressees and that you have read, understood and accept the terms of use for this website.

Decline